picking fresh colonies or growth of the test strain into a lawn seeded with lo6 indicator cells in 3 ml soft agar (up to 100 test strains per plate). Zones of growth inhibition were scored after 8-24 h incubation at 37 "C. In the overlay test, an unseeded agar plate was stab inoculated with the test strain and incubated for 24 h at 37 "C. The plate was then inverted and a 4 cm square pad of Whatman no. 1 filter paper placed in the lid. The pad was then soaked with chloroform (approx. 0.3 ml) and the dish closed for 30 min. The surface was then overlaid with 3 ml soft agar containing the indicator strain and the plate reincubated. Care was exercised when using plastic Petri dishes because toomuch chloroform would cause the lid and dish to stick together. When glass or metal lids were used the paper pad was removed before the agar overlay was added; this was not necessary with plastic dishes. Cross-streak tests for colicin sensitivity were as described by Davies & Reeves (19756) .
Plusmids. These were extracted from cells by the methods of Holmes & Quigley (1981) , which was ideal for small plasmids, or Kado & Liu (1981) , which was ideal for large plasmids. Methods for transformation and conjugation with selection for colicin immunity or for antibiotic resistance encoded by the Col plasmid or by the Tra+ mobilizing plasmid (see Table I ) were as used previously (Pugsley & Reeves, 1977; Mock & Pugsley, 1982) . Agarose gel electrophoresis was as described by Maniatis et al. (1982) using Trislacetate buffers in horizontal gels containing 0.5%, 0.8% or 1.2% agarose, depending on the size of the plasmid being examined. No attempt was made to determine the sizes of the Col plasmids other than to classify them as type I or type I1 (Lehrbach & Broda, 1984; Pugsley, 1984) .
RESULTS A N D DISCUSSION
Colicinlrnicrocin producing strains A collection of colicin-producing derivatives of E. coli K12 (Table 1) was obtained by transformation using plasmids extracted from the orginal producing strains, or by conjugation with the original strain with selection for immunity to the colicin produced by the donor strain. In cases where the original strain produced two colicins, selection was with a partially purified preparation of one only, or initially with a recipient which was sensitive to one only. The entire collection of strains was cross-checked for heterospecific immunity and, in two cases where the plasmid was found to confer immunity to a colicin other than the one encoded by the plasmid (pColE3-CA38 and pColIa-CA53), additional strains carrying in vitro constructed recombinant plasmids devoid of the additional immunity gene were added to the collection. The presence of a single plasmid of the appropriate size (Pugsley, 1984) was confirmed by agarose gel electrophoresis of plasmid extracts. Further details of the strains are given in Table 1 and in  Pugsley (1 984) .
The list of colicins shown in Table 1 is not exhaustive. At least three other colicins have been described. Colicin L (bacteriocin JF246) is produced by Serratia rnarcescens strain JF246 (Foulds, 1972) and also apparently by E. coli 398 (Davies & Reeves, 1975 b) and by three strains of S . rnarcescens recently isolated in our laboratory. In none of these cases was a plasmid detected in the producing strain or colicin immunity transferred to E. coli K12 by conjugation. E. coli strains CA46 and CA58 produce the related colicins G and H, respectively. Transfer of colicinogeny or colicin immunity from these strains to E. coli K12 was not achieved by conventional methods, even though the ColG and ColH plasmids have been tentatively identified (Lehrbach & Broda, 1984) . Similarly, Klebsiella pneurnoniae strain 492, which produces microcin E492, did not appear to carry a plasmid coding for the microcin or for immunity to it (V. de Lorenzo & A. P. Pugsley, unpublished observations). All of these strains, like those listed in Table 1 , are available both from the author and from the PRC.
Conditions for colicin production
Production of most colicins is regulated by the SOS system (Pugsley, 1984) , and therefore can be optimized by UV light irradiation or mitomycin C treatment of the Col+ cells, or by using G W 1000 [recA441, high level colicin production and SOS gene expression at 42 "C (Pugsley, 1981) J as the producing strain. Colicin production in plates was most conveniently tested by the patch or overlay methods (Methods). The former test had the advantage of requiring one cycle of incubation only, but had the disadvantage that inhibition zones were often small, particularly in the case of colicins B, H, Ia, Ib and M. The sensitivity of this test could be improved by including 0.1-0.25 yg mitomycin ml-1 in the agar. The sizes of the inhibition zones produced by the Col+ strains could be increased by using strains carrying a chromosomal mutation which inactivated the gene for the homologous colicin receptor protein (Tables 1 and 2 ). This was particularly effective with strains which produced very little colicin because the colicin which was released by the producing cells was largely resorbed onto the cell surface and was therefore unable to diffuse into the agar. Similarly, strains carrying rfa or tolAB mutations produced larger inhibition zones in plate tests, particularly if the strain produced small amounts of colicin. This seemed to be caused by the lysis of the colicin-producing cells within the colony (unpublished observation). Mutations inactivating colicin receptors were easily selected using the agents listed in Table 2 , while strains carrying rfa could be constructed by transducing them to kanamycin resistance using P1 phage grown on strain PAP102 (rfa : :Tn5). Such strains are not included in the collection available from PRC because the mutations affect the colicin sensitivity patterns of the producing bacteria, making them unsuitable for tests for colicin identity based on colicin immunity patterns (see below).
Production of colicin V, and of microcins C7, C17 (colicin X) and C492 was not induced by treatments which derepressed expression of SOS-regulated genes. Production of these antagonists was best observed using minimal glycerol medium rather than rich medium, and they could be further distinguished from other colicins by their ability to pass through cellophane membranes placed between the producing and indicator bacteria on the plate (Asensio et al., 1976) .
Colic in imm un ity and col icin -insens it ive mu tan ts
The specific colicin immunity of the E. coli K12 Col+/Mcc+ strains listed in Table 2 can be used as the basis of tests for the identification of new colicins. Some caution is required, however, because the strains may only be immune to low levels of colicin (Table 2 ). This was usually manifested by the decreased size of the inhibition zone rather than its complete absence when indicator strains are the same as the producing strains in patch, overlay or cross-streak tests. The occasional appearance of colicin-insensitive clones was noted in some of these 'partially immune' colicin-producing strains, most frequently in strains BZB2101 (ColA) and BZB2104 (ColEl), when the mutation was invariably of the btuB type (Mock & Pugsley, 1982) . In addition, the formation of unusual inhibition zones with certain combinations of Col+ indicator and producing bacteria was noted previously by Watson et al. (1981) . The strains which produce this phenomenon produce colicins in the E2-E8 series, and the unusual inhibition zones may be caused by low level, non-specific cross-immunity.
Tests for colicin immunity could be supplemented by tests using specific colicin-insensitive indicator strains. Mutants of E. coli K12 which lack the ability to adsorb colicin (resistant) or which adsorb colicin but remain unaffected by it (tolerant) are listed in Table 2 together with the most suitable agents for use in their selection. All of these mutants lack one or more membrane proteins which are directly or indirectly implicated in colicin adsorption or transport into the cell (Pugsley, 1984) . It should be noted that some of the insensitive mutants gave reactions of partial sensitivity on plate tests (Table 2) .
Use of the strains collection for the identiJication of colicins
In the present context, the main use of the colicin strains collection is to assist in the identification of a new colicin, or to confirm the identity of a colicin already under investigation. The decreased sensitivity of Col+ strains in Table 1 (relative to strain BZBlOll) to an unidentified colicin is a good indication of the (partial) identity of the two colicins. Similarly, reduced activity against strains listed in Table 2 is also useful in the preliminary identification of a colicin. Two problems which can arise are first, more than one colicin may be produced by a Col+ isolate, and second, Col plasmids listed in Table 1 may carry genes for the production of or immunity to as yet unidentified colicins (see Chak & James, 1984) . The first problem can be overcome by the judicious use of indicator strains carrying combinations of different Col plasmids and/or colicin-insensitivity mutations. For example, a strain carrying both btuB and tonB mutations was insensitive to over 80% of colicins produced by a collection of natural Col+ strains. Another approach is to select mutants which are insensitive to the colicin(s) produced by the uncharacterized Col+ strain; double mutants occur very infrequently during a single Table 1 .
Colicin-producing derivatives of E. coli K12 W3110
All strains are derivatives of E. coli K12 W3110; some of them carry a chromosomal gyrA mutation conferring resistance to nalidixate. Most plasmid designations indicate the strain from which the plasmid came (Reeves, 1972) ; plasmids isolated more recently in our laboratory, derivatives of Col plasmids carrying transposons, and in vitro constructed Col plasmids are given more conventional plasmid designations. Plasmids p APBZ 10 1 and pAPBZ 106 are pBR322-carrying fragments derived from pColE3-CA38 and pColIa-CA53, respectively, cloned into the EcoRI restriction site (Mock & Pugsley, 1982; Pugsley, 1983 
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E. coli CA53 (P. Fredericq via P. Reeves) t Plasmid types distinguished arbitrarily (Pugsley, 1983 (Pugsley, , 1984 on the basis of migration in agarose gels. 
colD S R R S S S S S S S S S S S S S S S S

S S S S S S S S S S S S S S S S S S S S R / T S R / T S mccE472 S S S S S S S S S S S S S S S S S S S S S
S S S ( R / T )
* All strains are derivatives of W3110 or BZBlOl1.
t Map positions are those given by Bachmann (1983) except those for cir (Boos et al., 1983) and rcx (M. Lavina and F. Moreno, personal communication), and were confirmed for the present mutations by phage P1-mediated co-transduction with appropriate mutations (Bachmann, 1983) . The map location of rem has not been determined.
selection cycle but the isolation of such mutants having characteristics of two classes of mutants listed in Table 2 is a good indication of the presence of two colicins. The problem of unidentified immunity genes can be overcome by transferring the Col plasmid into E. coli K12 (e.g. BZBlOl 1) and then performing a reciprocal colicin immunity test using strains listed in Table 1 . The shared identity of two colicins can only be inferred rather than confirmed by the above procedures. Positive identification depends on other techniques, including shared modes of action and physical and, chemical homology (including serological and amino acid sequence homology). The possible existence of microheterogeneity among colicins of a given type has not been investigated, but colicins which are apparently indistinguishable may be encoded by plasmids which are seemingly quite different [e.g. colicin E2 (Watson et al., 1983) and colicin N (unpublished observations)]. Indeed, the apparent high degree of homology of colicins E2 to E8 may represent one example of microheterogeneity among closely related colicins, although in this case the colicins can be distinguished by the absence of significant cross-immunity, differences in modes of action, and incomplete serological homology (Mock & Pugsley, 1982) .
The collection of strains described here has been used by us to identify new types of colicins or microcins. The initial stage was to plate samples of water, soil and other materials on MacConkey lactose agar, and to test Lac+ clones which developed at 37 "C for the production of an inhibitor active against strain BZBlOl 1 in patch tests on L agar + mitomycin or on M63 glycerol agar. Over 35% of 10000 colonies screened produced such an inhibitor. The producing clones were purified from the patch plate, and tested for activity against strain PAP15 (btuB tonA cir tsxfepA): 70% of the strains produced an inhibitor which was completely inactive against this strain, and a further 12% had substantially reduced activity. All but 35 of the remaining strains were inactive when tested against strain PAP 15 carrying a tonB mutation.
Eight of these 35 strains produced an inhibitor which had reduced activity against strains carrying ompF or ompR mutations, or pCHAP2 (ColS4), and produced inhibition zones which were similar to those produced by strains producing colicin S4 (large zones with high background growth of indicator strain). The remaining 27 strains were assumed to produce new colicins or microcins, possibly in combination with colicins which have been characterized. These results illustrate the utility of the strains in the collection, and indicate that yet more colicins or microcins are still to be identified and characterized. This work was supported by CNRS grant LA270 and by MIR grant 82-V-1279. I gratefully acknowledge contributions made by E. Lederberg, who encouraged me to make the strains available, by P. Fredericq, whose pioneering work on colicin identification made this work possible, and by these and others who provided bacteria and bacteriophages.
